One of Britain’s biggest respiratory drug makers has agreed to a takeover by the world’s largest tobacco company, in a $2.1b deal that will be seen as a crucial test of shareholders’ commitment to ethical investing.
Lord Myners (pictured), a former chairman at Marks & Spencer, branded the Vectura takeover a garage sale , saying the bid saga stank . Leading medical chiefs and physicians have also slammed the deal.
Le conseil d'administration de la société britannique Vectura, spécialisée dans les inhalateurs médicaux, a accepté l'offre de rachat du géant américain du tabac Philip Morris. Ce dernier a remporté la mise, pour 1,1 milliard de livres, après que le fonds d'investissement américain Carlyle a jeté l'éponge cette semaine.
Le associazioni anti-tabacco cercano di fermare l'acquisizione di Vectura, l'azienda inglese
specializzata in prodotti e servizi per i farmaci da inalazione contesa tra Philip Morris e Carlyle. (ANSA)